Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carotid endarterectomy.

H Handelsman1

  • 1DHHS, PHS, Agency for Health Care Policy and Research (AHCPR), Rockville, MD 20857.

Health Technology Assessment Reports
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Carotid endarterectomy, a surgery for carotid artery disease, has uncertain benefits for stroke prevention. Ongoing trials are needed to determine its effectiveness compared to nonoperative management for patients with transient ischemic attacks or asymptomatic stenosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cryosurgery for recurrent prostate cancer following radiation therapy.

Health technology assessment·2002
Same author

Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction.

Journal of the American College of Cardiology·2001
Same author

Dysrhythmia hazard after hospitalization for myocardial infarction: two ECG prognostic methods compared.

Journal of electrocardiology·2001
Same author

Signal-averaged electrocardiography.

Health technology assessment·1998
Same author

Lung-volume reduction surgery for end-stage chronic obstructive pulmonary disease.

Health technology assessment·1996
Same author

Haematopoietic stem-cell transplantation in multiple myeloma.

Cancer treatment reviews·1996
Same journal

Single and double lung transplantation.

Health technology assessment reports·1991
Same journal

Polysomnography and sleep disorder centers.

Health technology assessment reports·1991
Same journal

Hyperthermia in conjunction with cancer chemotherapy.

Health technology assessment reports·1991
Same journal

Intermittent positive pressure breathing (IPPB) therapy.

Health technology assessment reports·1991
Same journal

Cardiac rehabilitation programs.

Health technology assessment reports·1991
Same journal

Surface/specialty coil devices and gating techniques in magnetic resonance imaging.

Health technology assessment reports·1990
See all related articles

Area of Science:

  • Vascular Surgery
  • Neurology
  • Clinical Trials

Background:

  • Carotid endarterectomy removes atherosclerotic blockages from the carotid artery.
  • It's performed to reduce stroke risk and improve cerebral blood flow in patients with transient ischemic attacks (TIAs), asymptomatic stenosis, or stroke.
  • Existing studies on its efficacy have yielded conflicting or inconclusive results, with wide variations in complication rates.

Purpose of the Study:

  • To evaluate the established benefits of carotid endarterectomy for patients with carotid artery disease.
  • To compare surgical intervention with nonoperative management strategies.
  • To identify patient subsets who may benefit most from this procedure.

Main Methods:

  • Review of existing literature and clinical trial data.

Related Experiment Videos

  • Analysis of morbidity and mortality rates associated with the procedure.
  • Assessment of studies comparing carotid endarterectomy to nonoperative management.
  • Main Results:

    • No prospective clinical trial has definitively proven carotid endarterectomy superior or inferior to nonoperative management for any patient group.
    • Evidence supporting benefits for patients with TIAs is inconclusive.
    • The advantages for asymptomatic patients with carotid artery disease are even less clear.

    Conclusions:

    • The benefits of carotid endarterectomy remain indeterminate pending results from ongoing prospective, randomized, controlled clinical trials.
    • Current alternative treatments have not demonstrated superior therapeutic outcomes.
    • Further research is required to establish optimal therapy and identify patient subgroups likely to benefit.